{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:42:28Z","timestamp":1778712148735,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.rgmx.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T15:02:49Z","timestamp":1446562969000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en M\u00e9xico"],"prefix":"10.1016","volume":"81","author":[{"given":"O.","family":"Novoa-Far\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Frati-Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Peredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Flores-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Novoa-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Galicia-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Romero-Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10 Supl","key":"10.1016\/j.rgmx.2015.07.003_bib0325","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1097\/01.inf.0000142463.72442.91","article-title":"Diarrhea morbility and mortality in Mexican children: Impact of rotavirus disease","volume":"23","author":"Vel\u00e1zquez","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0330","unstructured":"Farthing M, Lindberg G, Dite P, et al. Acute diarrhea. World Gastroenterology Organization. 2008. WGO Practice Guidelines. p. 1-31."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0335","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0036-36342009000400004","article-title":"Mortalidad por enfermedad diarr\u00e9ica en menores, antes y despu\u00e9s de la introducci\u00f3n de la vacuna contra el rotavirus","volume":"51","author":"Esparza Aguilar","year":"2009","journal-title":"Salud Pub Mex."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0340","unstructured":"SUIVE\/DGE\/SALUD\/informaci\u00f3n epidemiol\u00f3gica de morbilidad. Anuario 2011."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0345","first-page":"1","article-title":"Caracterizaci\u00f3n de aislados de Escherichia coli 0157: H7 en canales de bovinos y porcinos mediante PCR. Marzo 2009","volume":"10","author":"Gallegos","year":"2009","journal-title":"Rev Cient\u00edfica (Maracaibo)."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0350","unstructured":"S\u00e1nchez MLG, Gonz\u00e1lez LL. Yersinia enterocolitica: prevalencia en ni\u00f1os con diarrea atendidos en el Hospital Municipal de C\u00f3rdoba durante 2010-2011 [consultado 10 Ago 2014]. Disponible en: http:\/\/www.cobico.com.ar\/wp-content\/archivos\/2013\/02\/PUBLICACION-DRA-SANCHEZ.pdf"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0355","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00006454-200009000-00022","article-title":"Surgical complications of Shigellosis in children","volume":"19","author":"Mir\u00f3n","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0360","first-page":"216","article-title":"Sensibilidad de Campylobacter jejuni a ocho antibi\u00f3ticos en cepas aisladas de muestras cl\u00ednicas de ni\u00f1os","volume":"16","author":"Campos","year":"2003","journal-title":"Rev Esp Quimioterap."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0365","first-page":"138","article-title":"Susceptibilidad a los antimicrobianos y factores de virulencia en cepas de Vibrio cholerae no-01 aisladas de pacientes con enfermedad diarreica aguda","volume":"19","author":"Cabrera","year":"2008","journal-title":"Rev Biomed."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0370","unstructured":"Evaluaci\u00f3n de riesgos de Vibrio spp. en pescados y mariscos. Ginebra: WHO\/FAO 2004 [consultado 20 Ago 2014]. Disponible en: http:\/\/www.fao.org\/docrep\/008\/y8145s\/y8145s08.htm#TopOfPage"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0375","first-page":"565","article-title":"Prevalencia y susceptibilidad a los antibi\u00f3ticos de cepas m\u00f3viles de Aeromonas aisladas del osti\u00f3n de mangle (Crassostrea rhizoplorae)","volume":"22","author":"Mu\u00f1oz","year":"2012","journal-title":"Rev Cient\u00edfica"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4067\/S0716-10182011000200009","article-title":"Caracterizaci\u00f3n fenot\u00edpica de cepas de Aeromonas aisladas de pacientes con enfermedad diarreica aguda en Cuba","volume":"28","author":"Bravo","year":"2011","journal-title":"Rev Chil Infect."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0385","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0140-6736(91)90868-P","article-title":"Association of Escherichia coli Hep-2-adherence patterns with the type and duration of diarrhea","volume":"337","author":"Cravioto","year":"1991","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0390","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.11.1.142","article-title":"Diarrheagenic Escherichia coli","volume":"11","author":"Nataro","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0395","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3476(86)81050-2","article-title":"Incidence of bacteremia in infants with Salmonella enteritidis","volume":"108","author":"Torrey","year":"1986","journal-title":"J Pediatr."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0400","first-page":"1","article-title":"World Gastroenterology Organization practice guideline: Acute diarrhea","author":"Farthing","year":"2008","journal-title":"WGO Practice Guidelines"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0405","first-page":"510","article-title":"Resistencia de bacterias respiratorias y ent\u00e9ricas a los antibi\u00f3ticos","volume":"40","author":"Sol\u00f3rzano","year":"1998","journal-title":"Salud Pub M\u00e9xico"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0410","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/clinids\/22.6.1019","article-title":"Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin","volume":"22","author":"Dryden","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0415","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archinte.1990.00390150047009","article-title":"Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults","volume":"150","author":"Goodman","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0420","first-page":"1464","article-title":"Multirresistencia antimicrobiana en cepas de Shigella spp. en una comuna semirural del \u00e1rea norte de Santiago","volume":"126","author":"Prado","year":"1998","journal-title":"Rev Med Chil."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0425","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/infdis\/168.5.1304","article-title":"Ciprofloxacin and trimetropin-sulfametoxazol versus placebo in acute uncomplicated Salmonella enteritidis: A double-blind trial","volume":"168","author":"S\u00e1nchez","year":"1998","journal-title":"J Infect Dis."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0430","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/323814","article-title":"Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical Trial","volume":"33","author":"Dupont","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0435","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1756283X10372985","article-title":"Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: A prospective pilot trial","volume":"3","author":"Patrick Basu","year":"2010","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0440","first-page":"141","article-title":"Rifaximina","volume":"17","author":"Gobernado","year":"2004","journal-title":"Rev Esp Quimioterap."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0445","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with Irritable Bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2015.07.003_bib0450","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000089776","article-title":"Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic","volume":"73","author":"Scarpignato","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0455","first-page":"1","article-title":"Evaluaci\u00f3n de la congelaci\u00f3n para la conservaci\u00f3n de especies bacterianas","volume":"3","author":"S\u00e1nchez-Leal","year":"2005","journal-title":"Nova-Pub Cient"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0460","unstructured":"Zimbro MJ, Power DA, Miller SM, et al., eds. Difco & BBL Manual. Manual of microbiological culture media. 2nd ed. Sparks: BD Diagnostics-Diagnostic Systems; 2009."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0465","unstructured":"Instructivo Panel Gram Positivo. MicroScan. Siemens Healthcare Diagnostic, M\u00e9xico, 2013."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0470","unstructured":"Instructivo Panel ID-GNB. Vitek 2 Biomeriux Inc. M\u00e9xico, 2013."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0475","unstructured":"Instructivo Panel Gram Negativo. MicroScan. Siemens Healthcare Diagnostics. M\u00e9xico, 2013."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0480","unstructured":"Instructivos Bio-rad Laboratories. Antisueros bacterianos. M\u00e9xico, 2013."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0485","unstructured":"Instructivos Phadebact Monoclonal GC Test. Suecia, 2012."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0490","unstructured":"Instructivos Oxoid Limited. Dryspot E. coli O 157. United Kingdom, 2013."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0495","unstructured":"Instructivos Sanofi-Pasteur. Antisueros bacterianos. 2012. M\u00e9xico. France."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0500","unstructured":"Instructivos Laboratorios \u00abO\u00bb Beli. Antisueros bacterianos. 2012. M\u00e9xico DF."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0505","unstructured":"Instructivos Probac do Brazil. Antisueros bacterianos. 2012. Sao Paulo, Brazil."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0510","unstructured":"Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. M100-S22 2012; 32 (3)."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0515","series-title":"Diagnostic Microbiology","first-page":"131","author":"Koneman","year":"2000"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0520","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4067\/S0716-10182011000200009","article-title":"Caracterizaci\u00f3n fenot\u00edpica de cepas de Aeromonas aisladas de pacientes con enfermedad diarr\u00e9ica aguda en Cuba","volume":"28","author":"Bravo","year":"2011","journal-title":"Rev Chil Infect."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0525","doi-asserted-by":"crossref","first-page":"e105031","DOI":"10.1371\/journal.pone.0105031","article-title":"Use of populations-based surveillance to define the high incidence of shigellosis in an urban slum in Nairobi, Kenya","volume":"9","author":"Njuguna","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0530","first-page":"45","article-title":"Diarrheagenic Escherichia coli in acute gastroenteritis in infants in North-West Italy","volume":"34","author":"Amisano","year":"2011","journal-title":"New Microbiol"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0535","first-page":"151","article-title":"Shigella sepsis","volume":"135","author":"Duncan","year":"1981","journal-title":"Am J Dis Child."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0540","first-page":"464","article-title":"Principales caracter\u00edsticas y diagn\u00f3stico de los grupos pat\u00f3genos de Escherichia coli","volume":"44","author":"Rodr\u00edguez \u00c1ngeles","year":"2002","journal-title":"Salud Pub Mex"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0545","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.45.1.212-216.2001","article-title":"In vitro antimicrobial susceptibility testing of bacterial entheropathogens causing traveler's diarrhea in four geographic regions","volume":"45","author":"Gomi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0550","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/AAC.00739-10","article-title":"In vitro Antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008","volume":"55","author":"Ouyang-Latimer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0555","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2014.01.026","article-title":"In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travelers returning to the UK","volume":"43","author":"Hopkins","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0560","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0565","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s10096-014-2175-y","article-title":"Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008-2012, northern Taiwan","volume":"33","author":"Wang","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2015.07.003_bib0570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in vitro and in vivo antibacterial activity \u2014A review","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0575","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci","volume":"10","author":"DuPont","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0580","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","author":"De Leo","year":"1986","journal-title":"Drugs Exptl Clin Res"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0585","first-page":"54","article-title":"Antibiotics resistance of enterotoxigenic and entroaggregative Escherichia coli isolated from gastroenteritis cases","volume":"2","author":"Barati","year":"2012","journal-title":"Asian J Biomed Pharm Sci"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0590","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3343\/alm.2013.33.2.111","article-title":"Surveillance of Antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011","volume":"33","author":"Yang","year":"2013","journal-title":"Ann Lab Med."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0595","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/fpd.2013.1629","article-title":"Non typhoidal Salmonella infection in children with acute gastroenteritis: Prevalence, serotypes and antimicrobial resistance in Shanghai, China","volume":"11","author":"Li","year":"2014","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0600","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4067\/S0716-10182013000600007","article-title":"Patrones de susceptibilidad antimicrobiana de cepas de Shigella sonnei aisladas durante tres periodos diferentes en la regi\u00f3n metropolitana","volume":"30","author":"Marcoleta","year":"2013","journal-title":"Chile. Rev Chil Infect."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0605","first-page":"23","article-title":"Eficacia y seguridad de rifaximina en el tratamiento del episodio diarr\u00e9ico agudo en ni\u00f1os de seis meses a cinco a\u00f1os","volume":"16","author":"Mac\u00edas Parra","year":"2002","journal-title":"Rev Enf Inf Pediat."},{"key":"10.1016\/j.rgmx.2015.07.003_bib0610","first-page":"336","article-title":"Infectious diarrhea in the aged: Controlled clinical trial of rifaximin","volume":"7","author":"Della Marchina","year":"1988","journal-title":"Chemiother"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0615","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers\u2019 diarrhea","volume":"74","author":"Taylor","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0620","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2007.02.004","article-title":"Treatment of travelers\u2019 diarrhea: A randomized trial comparing rifaximin, rifaximin plus loperamide and loperamide alone","volume":"5","author":"DuPont","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0625","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/591126","article-title":"Emergency department visits for antibiotic-associated adverse events","volume":"47","author":"Shehab","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0630","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JCM.02460-08","article-title":"Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007","volume":"47","author":"Vrints","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rgmx.2015.07.003_bib0635","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4269\/ajtmh.2005.72.851","article-title":"Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile","volume":"72","author":"Full\u00e1","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2015.07.003_bib0640","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/clinids\/24.Supplement_1.S102","article-title":"Antimicrobial resistance in organisms causing diarrheal disease","volume":"24","author":"Sack","year":"1997","journal-title":"Clin Infect Dis"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090615000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090615000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T02:56:28Z","timestamp":1567306588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090615000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0375090615000798"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2015.07.003","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en M\u00e9xico","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}